Imara to webcast conference call of third quarter financial results

Boston, oct. 29, 2020 (globe newswire) -- imara inc. (nasdaq: imra), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on thursday, november 5, 2020, at 8:30 a.m. et to discuss its third quarter 2020 financial results and recent business highlights.
ELVN Ratings Summary
ELVN Quant Ranking